cilastatin has been researched along with Leukemia, Myeloid, Acute in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arima, H; Hanada, S; Kawahata, H; Makino, T; Nakahara, K; Shimotakahara, S; Takatsuka, Y; Takeuchi, S; Uozumi, K; Utsunomiya, K | 1 |
| Bruserud, O | 1 |
| Asano, Y; Harada, M; Kozuru, M; Murakawa, M; Niho, Y; Okamura, T; Sawae, Y; Shibuya, T; Taniguchi, S; Toyoshima, T | 1 |
| Akasaka, K; Kageyama, T; Kitani, T; Nasu, K; Nin, T; Ohyabu, H; Sannomiya, Y; Tatsumi, N; Tominaga, N; Yonezawa, T | 1 |
1 trial(s) available for cilastatin and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
[Therapeutic effects of imipenem/cilastatin sodium against severe infections in patients with hematopoietic disorders. Hanshin Infection Study Group].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Drug Combinations; Female; Humans; Imipenem; Infusions, Intravenous; Leukemia, Myeloid, Acute; Leukocyte Count; Lymphoma; Male; Middle Aged | 1989 |
3 other study(ies) available for cilastatin and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
[Acute myelogenous leukemia with spontaneous remission simultaneous with improvement of severe infection: report of 2 cases].
Topics: Abscess; Amikacin; Anti-Bacterial Agents; Anus Diseases; Cellulitis; Cilastatin; Drug Therapy, Combination; Humans; Imipenem; Leukemia, Myeloid, Acute; Male; Middle Aged; Protease Inhibitors; Remission, Spontaneous; Thienamycins | 1999 |
Effects of imipenem and cilastatin on human T-lymphocytes derived from acute leukemia patients with chemotherapy-induced leucopenia: studies of T-lymphocyte responses in the presence of acute myelogenous leukemia (AML) blast accessory cells.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cilastatin; Cytokines; Dose-Response Relationship, Drug; Female; Humans; Imipenem; Interleukin-2; Leukemia, Myeloid, Acute; Leukopenia; Lymphocyte Activation; Male; Middle Aged; T-Lymphocytes | 2000 |
[Therapeutic evaluation of imipenem/cilastatin sodium for bacterial infections in patients with hematological diseases].
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Cilastatin; Drug Evaluation; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Imipenem; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged | 1992 |